Cancer survivors' self-efficacy to self-manage in the year following primary treatment

C Foster, M Breckons, P Cotterell, D Barbosa, L Calman, J Corner, D Fenlon, R Foster, C Grimmett, A Richardson, P W Smith, C Foster, M Breckons, P Cotterell, D Barbosa, L Calman, J Corner, D Fenlon, R Foster, C Grimmett, A Richardson, P W Smith

Abstract

Purpose: Cancer survivors are increasingly expected to manage the consequences of cancer and its treatment for themselves. There is evidence that self-efficacy is important for successful self-management and that this can be enhanced with support. The purpose of this study was to assess self-efficacy to manage problems in the year following primary treatment.

Methods: This cross-sectional online survey included cancer survivors who had completed their treatment within the past 12 months. Self-efficacy was assessed and variables expected to be associated with self-efficacy were measured using validated scales including quality of life, well-being, illness perceptions, depression and social support.

Results: One hundred eighty-two respondents (mean age 50; 81% female) completed the survey. They had been treated for a range of cancers; most commonly breast (45%). Self-efficacy scores varied between individuals and according to the illness-related task to be managed. Respondents were least confident in managing fatigue and most confident in accessing information about their cancer. Individuals most likely to report low self-efficacy were women, those experiencing higher levels of pain and/or depression, lower well-being scores, lower socio-economic status, low levels of social support, or a more negative perception of cancer.

Conclusions: Self-efficacy to self-manage problems faced as a consequence of cancer and its treatment can vary widely in the year following treatment. Fatigue may be particularly difficult to manage.

Implications for cancer survivors: Variations in self-efficacy highlight the importance of assessing specific problems faced and people's confidence to manage them in order to tailor appropriate self-management support.

Figures

Fig. 1
Fig. 1
Recovery of health and well-being in cancer survivorship [11]
Fig. 2
Fig. 2
Self-efficacy to manage consequences of cancer and its treatment. Measured by the Cancer Survivors Self-Efficacy Scale (high score denotes higher self-efficacy)

References

    1. World Cancer Research Fund//American Institute for Cancer Research . Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington: AICR; 2007.
    1. Corner J. Addressing the needs of cancer survivors: issues and challenges. Expert Rev Pharmacoecon Outcomes Res. 2008;8(5):443–51. doi: 10.1586/14737167.8.5.443.
    1. Hewitt M, Rowland J, Yancik R. Cancer survivors in the United States: age, health and disability. J Gerontol A Biol Sci Med Sci. 2003;58(1):82–91. doi: 10.1093/gerona/58.1.M82.
    1. Foster C, Wright D, Hill H, Hopkinson J, Roffe L. Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eur J Cancer Care. 2009;18:223–47. doi: 10.1111/j.1365-2354.2008.01001.x.
    1. Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N, Ream E, Young A, Richardson A. Patients’ supportive care needs beyond the end of cancer treatment: a prospective. longitudinal survey. J Clin Oncol. 2009;27(36):6172–9. doi: 10.1200/JCO.2009.22.5151.
    1. DH, Macmillan Cancer Support & NHS Improvement. National Cancer Survivorship Initiative Vision. 2010. . Accessed 20/3/2013.
    1. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. National Academies Press. 2006. . Accessed 10 April 2013.
    1. Shippee N, Shah N, May C, Mair F, Montori V. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65(10):1041–51. doi: 10.1016/j.jclinepi.2012.05.005.
    1. Barlow J, Bancroft G, Turner A. Self-management training for people with chronic disease: a shared learning experience. J Health Psychol. 2005;10(6):863–72. doi: 10.1177/1359105305057320.
    1. Lorig K, Sobel D, Ritter P, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256–62.
    1. Foster C, Fenlon D. Recovery and self-management support following primary cancer treatment. Br J Cancer. 2011;105(Suppl 1):S21–8. doi: 10.1038/bjc.2011.419.
    1. Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs: Prentice Hall; 1986.
    1. Bandura A. Social learning theory. New York: General Learning Press; 1977.
    1. Lev E, Daley K, Connor N, Reith M, Fernandez C, Owen S. An intervention to increase quality of life and self-care self-efficacy and decrease symptoms in breast cancer patients. Res Theory Nurs Pract. 2001;15(3):277–94.
    1. Lev E. Bandura's theory of self-efficacy: applications to oncology. Res Theory Nurs Pract. 1997;11(1):21–37.
    1. Hofstetter C, Sallis J, Hovell M. Some health dimensions of self-efficacy: analysis of theoretical specificity. Soc Sci Med. 1990;31(9):1051–6. doi: 10.1016/0277-9536(90)90118-C.
    1. Rodgers W, Murray T, Courneya K, Bell G, Harber V. The specificity of self-efficacy over the course of a progressive exercise programme. Appl Psychol: Health Well-Being. 2009;1(2):211–32.
    1. Stanford Patient Education Research Center. Self-efficacy for managing chronic disease 6-item scale. 2013. Accessed 20/3/2013.
    1. Buckelew S, Huyser B, Hewett J, Parker J, Johnson J, Conway R, Kay D. Self-efficacy predicting outcome among fibromyalgia subjects. Arthritis Care Res. 1996;9(2):97–104. doi: 10.1002/1529-0131(199604)9:2<97::AID-ANR1790090205>;2-F.
    1. Kidd L. An exploration of patients’ perceived control, self efficacy and involvement in self care during chemotherapy for colorectal cancer. University of Stirling: PhD thesis, 2007.
    1. University of Southampton. iSurvey. 2012. . Accessed 20/3/2013.
    1. Wiljer D, Leonard K, Urowitz S, Apatu E, Massey C, Quartey N, Catton P. The anxious wait: assessing the impact of patient accessible EHRs for breast cancer patients. BMC Med Inform Decis Making. 2010;10:46. doi: 10.1186/1472-6947-10-46.
    1. Foster C, Breckons M, Hankins M, Fenlon D, Cotterell P. Developing a scale to measure self-efficacy to self-manage problems following cancer treatment. Psycho-Oncology. 2013;22(S 1):16.
    1. Avis N, Smith K, McGraw S, Smith R, Petronis V, Carver C. Assessing quality of life in adult cancer survivors (QLACS) Qual Life Res. 2005;14:1007–23. doi: 10.1007/s11136-004-2147-2.
    1. Cummins R, Eckersley R, Pallant J, Van Vugt J, Misajon R. Developing a national index of subjective wellbeing: the Australian unity wellbeing index. Soc Indic Res. 2003;64:159–90. doi: 10.1023/A:1024704320683.
    1. Geyh S, Fellinghauer B, Kirchberger I, Post M. Cross-cultural validity of four quality of life scales in persons with spinal cord injury. Health Qual Life Outcomes. 2010;8:94. doi: 10.1186/1477-7525-8-94.
    1. Forjaz M, Prieto-Flores M-E, Rodriguez-Blazquez A, Fernandez-Mayoralas G, Rojo-Perez F, Martinez-Martin P. Measurement properties of the Community Wellbeing Index in older adults. Qual Life Res, 2010.
    1. International Wellbeing Group. 2006. Personal Wellbeing Index. Melbourne: Australian Centre on Quality of Life, Deakin University. Accessed 20/3/2013.
    1. Broadbent E, Petrie K, Main J, Weinman J. The Brief Illness Perception Questionnaire. J Psychosom Res. 2006;60:631–7. doi: 10.1016/j.jpsychores.2005.10.020.
    1. Mols F, Denollet J, Kaptein A, Reemst P, Thong M. The association between Type D personality and illness perceptions in colorectal cancer survivors: a study from the population-based PROFILES registry. 2012; 73: 232-239.
    1. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. doi: 10.1177/014662167700100306.
    1. Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G. Screening for depression in head and neck cancer. Psychooncology. 2004;13:269–80. doi: 10.1002/pon.734.
    1. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D) J Psychosom Res. 1999;46(5):437–43. doi: 10.1016/S0022-3999(99)00004-5.
    1. Sherbourne C, Stewart A. The MOS social support survey. Soc Sci Med. 1991;32(6):705–14. doi: 10.1016/0277-9536(91)90150-B.
    1. Kornblith A, Herndon J, Weiss R, Zhang C, Zuckerman E, Rosenberg S, Mertz M, Payne D, Massie M, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003;98(4):679–89. doi: 10.1002/cncr.11531.
    1. Menard S. Applied logistic regression analysis. Thousand Oaks: Sage; 1995.
    1. Myers R. Classical and modern regression with applications. Boston: Duxbury Press; 1990.
    1. Bower J, Ganz P, Desmond K, Rowland J, Meyerowitz B, Belin T. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–53.
    1. Freund T, Gensichen J, Goetz K, Szecsenyi J, Mahler C. Evaluating self-efficacy for managing chronic disease: psychometric properties of the six-item Self-Efficacy Scale in Germany. J Eval Clin Pract. 2011;19:39–43. doi: 10.1111/j.1365-2753.2011.01764.x.
    1. Fenlon D, Richardson A, Addington-Hall J, Smith P, Corner J, Winter J, Foster C. A cohort study of the recovery of health and wellbeing following colorectal cancer (CREW study): protocol paper. BMC Health Serv Res. 2012;12:90. doi: 10.1186/1472-6963-12-90.
    1. Cancer Research UK. Cancer incidence statistics. Accessed 10/4/2013.
    1. Office for National Statistics. 2011 Census, key statistics for local authorities in England and Wales Accessed 10 Apr 2013.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever